Lidocaine intravesicular - Plethora Solutions

Drug Profile

Lidocaine intravesicular - Plethora Solutions

Alternative Names: Intravesical alkalized lidocaine (PSD597) - Plethora Solutions; PSD 597

Latest Information Update: 28 May 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Queens University
  • Developer Plethora Solutions
  • Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Interstitial cystitis; Perioperative pain

Most Recent Events

  • 24 Sep 2013 Biomarkers information updated
  • 25 Feb 2013 Discontinued - Phase-II for Interstitial cystitis in Canada (Intravesicular)
  • 25 Feb 2013 Discontinued - Phase-II for Interstitial cystitis in USA (Intravesicular)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top